Changes in the Fibrinolytic System of Patients Infected with Severe Acute Respiratory Syndrome Coronavirus 2.

Esra'a Abudouleh Fatimah S AlhamlanArwa A Al-QahtaniMarie Fe F BoholAmal Al HazzaniKhadija KhorfanMorad AlkaffTarek M Owaidah Ahmed Ali Al-Qahtani

Published in: Journal of clinical medicine (2023)

Hypofibrinolysis was the most prevalent condition among patients with severe COVID-19. In this study, several coagulation markers were elevated, making them suitable prognostic markers for hypofibrinolysis.

Keyphrases

respiratory syndrome coronavirus
sars cov
coronavirus disease
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
drug induced